1098184-18-9

Basic information

• Product Name: 4-nitrophenyl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate
• Synonyms: 4-nitrophenyl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate
• CAS NO: 1098184-18-9
• Molecular Weight: 293.199
• Mol File: 1098184-18-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-nitrophenyl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-nitrophenyl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate(1098184-18-9)
• EPA Substance Registry System: 4-nitrophenyl (1,1,1-trifluoro-2-methylpropan-2-yl) carbonate(1098184-18-9)

Safety Data

• Hazardous Substances Data: 1098184-18-9(Hazardous Substances Data)

Upstream product

• 507-52-8 2-(trifluoromethyl)-2-propanol 
• 7693-46-1 4-Nitrophenyl chloroformate 

Relevant articles and documents

Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants

The three pan-genotypic HCV NS3/4A protease inhibitors (PIs) currently in clinical use - grazoprevir, glecaprevir, and voxilaprevir - are quinoxaline-based P2-P4 macrocycles and thus exhibit similar resistance profiles. Using our quinoxaline-based P1-P3 m

2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE

The invention provides certain benzoxazine compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, Ra, Rb, Rc, Rd, Rg, and Cy are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds of the Formula (I) or pharmaceutically acceptable salts thereof, and methods of using the compounds of the Formula (I) or pharmaceutically acceptable salts thereof or pharmaceutical compositions comprising the same for treating diseases or conditions mediated by RORgammaT.

NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION

The present invention relates to a compound of Formula (I): wherein: R1 is H or C1-2 alkyl; R2 is H or C1-3 alkyl; R3 and R4 are each independently H or C1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents